Watch the recording of this lively and entertaining MEDTalk presented by three prominent GPs with deep expertise in diabetes as they debate whether, in this new realm of diabetes management, the older sovereign, insulin, should now be consigned to the retirement village of history.
This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.
Dr Tom Dover (Endocrinologist, Queensland Health) and Dr Ashraf Saleh (GP, Toowomba, Qld) discuss the role of injectable therapies in the ongoing management of type 2 diabetes, and outline methods to reduce barriers and improve patient outcomes.
Gonzalo Jacome, Senior Staff Clinician, Centre for Eye Health, UNSW discusses how general practitioners can provide effective first-line care for a range of eye conditions. Ways to diagnose eye conditions in a telehealth consultation are explored, as well as the identification of ocular emergencies and coordinating care with optometrists in glaucoma management.
Select the best management options for a type 2 diabetes patient on insulin therapy in this case study quiz.
Recently published consensus statement: Practical guidance for the use of IDegAsp in type 2 diabetes
Dr Sarah Glastras provides practical advice on the usage of the insulin degludec/insulin aspart coformulation, and outlines its role in insulin initiation and intensification in light of the recently released consensus statement.
Decide on the best course of action for a patient at risk of diabetes-related retinopathy in this case study quiz.
This guide summarises key information about DR in patients with type 2 diabetes and the GP’s role in screening, management and referral.